253 related articles for article (PubMed ID: 11845988)
21. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
Schlage P; Mezo G; Orbán E; Bosze S; Manea M
J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for the formation of anthracycline-DNA adducts.
Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
[TBL] [Abstract][Full Text] [Related]
23. Effect of DNA-interacting drugs on phage T7 RNA polymerase.
Piestrzeniewicz M; Studzian K; Wilmańska D; Płucienniczak G; Gniazdowski M
Acta Biochim Pol; 1998; 45(1):127-32. PubMed ID: 9701505
[TBL] [Abstract][Full Text] [Related]
24. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
25. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Taatjes DJ; Fenick DJ; Koch TH
J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
[TBL] [Abstract][Full Text] [Related]
26. Interactions of novel morpholine and hexamethylene derivatives of anthracycline antibiotics with DNA.
Piestrzeniewicz MK; Wilmańska D; Szemraj J; Studzian K; Gniazdowski M
Z Naturforsch C J Biosci; 2004; 59(9-10):739-48. PubMed ID: 15540609
[TBL] [Abstract][Full Text] [Related]
27. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
Babudri N; Pani B; Tamaro M; Monti-Bragadin C; Zunino F
Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
[TBL] [Abstract][Full Text] [Related]
28. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
[TBL] [Abstract][Full Text] [Related]
29. [Structure and activity of anthracyclines].
Lavelle F
Pathol Biol (Paris); 1987 Jan; 35(1):11-9. PubMed ID: 3550604
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
[TBL] [Abstract][Full Text] [Related]
31. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
32. Studies of anthracycline--DNA complexes by circular dichroism.
Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
Ghirmai S; Mume E; Tolmachev V; Sjöberg S
Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
Maniez-Devos DM; Baurain R; Lesne M; Trouet A
J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological properties of N2-substituted spin-labeled analogues of actinomycin D.
Sinha BK; Cox MG; Chignell CF; Cysyk RL
J Med Chem; 1979 Sep; 22(9):1051-5. PubMed ID: 226705
[TBL] [Abstract][Full Text] [Related]
36. [Derivatives of daunorubicin containing an inosine fragment].
Olsuf'eva EN; Todorova NP; Iartseva IV; Rozynov BV; Shepelevtseva NG; Preobrazhenskaia MN
Bioorg Khim; 1989 Nov; 15(11):1569-72. PubMed ID: 2624594
[TBL] [Abstract][Full Text] [Related]
37. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
Cini-Neri G; Neri B
Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
[TBL] [Abstract][Full Text] [Related]
38. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
[TBL] [Abstract][Full Text] [Related]
39. Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubules.
Hjelle JT; Baurain R; Masquelier M; Trouet A
J Pharmacol Exp Ther; 1984 May; 229(2):372-80. PubMed ID: 6585548
[TBL] [Abstract][Full Text] [Related]
40. Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis.
Mizuno NS; Zakis B; Decker RW
Cancer Res; 1975 Jun; 35(6):1542-6. PubMed ID: 1169109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
